Abstract: Disclosed herein are hybrid multivalent vaccine or immunogenic compositions comprising (i) one or more influenza virus proteins selected from one or more influenza virus hemagglutinin (HA) proteins, one or more influenza virus neuraminidase (NA) proteins, or a combination thereof; and (ii) one or more ribonucleic acid molecules encoding one or more influenza virus proteins selected from one or more influenza virus HA proteins, one or more influenza virus NA proteins, or a combination thereof. Also disclosed are methods of using the vaccine or immunogenic compositions.
| # | Name | Date |
|---|---|---|
| 1 | 202417041451-TRANSLATIOIN OF PRIOIRTY DOCUMENTS ETC. [28-05-2024(online)].pdf | 2024-05-28 |
| 2 | 202417041451-STATEMENT OF UNDERTAKING (FORM 3) [28-05-2024(online)].pdf | 2024-05-28 |
| 3 | 202417041451-Sequence Listing in txt [28-05-2024(online)].txt | 2024-05-28 |
| 4 | 202417041451-Sequence Listing in PDF [28-05-2024(online)].pdf | 2024-05-28 |
| 5 | 202417041451-REQUEST FOR EXAMINATION (FORM-18) [28-05-2024(online)].pdf | 2024-05-28 |
| 6 | 202417041451-NOTIFICATION OF INT. APPLN. NO. & FILING DATE (PCT-RO-105-PCT Pamphlet) [28-05-2024(online)].pdf | 2024-05-28 |
| 7 | 202417041451-FORM 18 [28-05-2024(online)].pdf | 2024-05-28 |
| 8 | 202417041451-FORM 1 [28-05-2024(online)].pdf | 2024-05-28 |
| 9 | 202417041451-DRAWINGS [28-05-2024(online)].pdf | 2024-05-28 |
| 10 | 202417041451-DECLARATION OF INVENTORSHIP (FORM 5) [28-05-2024(online)].pdf | 2024-05-28 |
| 11 | 202417041451-COMPLETE SPECIFICATION [28-05-2024(online)].pdf | 2024-05-28 |
| 12 | 202417041451-FORM-26 [26-08-2024(online)].pdf | 2024-08-26 |
| 13 | 202417041451-FORM 3 [16-11-2024(online)].pdf | 2024-11-16 |